The Newsroom
Item 1 of 3
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...
Item 2 of 3
AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes
Item 3 of 3
AdventHealth East Orlando First in Florida to Earn Advanced Foot & Ankle Surgery Certification from DNV
Recent Stories at AdventHealthMD
-
-
Your Gut Does Not Treat All Calories Equally
-
National Groups Look to AdventHealth for Expertise in Artificial Intelligence
-
AdventHealth is First in Florida to Deploy Next-Generation Surgical Robot
-
AdventHealth Cancer Institute is Among the First in the World to Offer a New Phase II Clinical Trial of a Novel, Customized Precision Immunotherapy for Patients with High-risk Muscle-invasive Urothelial Carcinoma
-
Lighting the Way: How One AdventHealth Physician Inspires the Next Generation of Doctors Through Mentoring
-
How to Reduce Florida’s Drug-Related Illnesses and Deaths: “You Cannot Arrest Your Way Out of this Problem"
-
AdventHealth Waterman Introduces Robotic-Assisted Procedure for Early Lung Cancer Detection
-
AdventHealth Waterman Begins Expansion on Inpatient Rehabilitation Unit